![Ron Hunt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ron Hunt
Direttore/Membro del Consiglio presso
RALLYBIO CORPORATION
Patrimonio netto: - $ in data 31/08/2026
Profilo
Mr. Ronald M.
Hunt is an Independent Director at Rallybio Corp.
and a Co-Founder/Managing Director at New Leaf Venture Partners LLC.
He is on the Board of Directors at Rallybio Corp., CuraSen Therapeutics, Inc., Iterum Therapeutics International Ltd., Iterum Therapeutics US Holding Ltd., Qlaris Bio, Inc. and ReViral Ltd. Mr. Hunt was previously employed as an Independent Director by Harpoon Therapeutics, Inc., a Chairman by Iterum Therapeutics Plc, an Independent Director by Neuronetics, Inc., an Independent Director by Relypsa, Inc., an Independent Director by Durata Therapeutics, Inc., a Partner by Sprout Group, a Principal by Johnson & Johnson, a Consultant by Coopers & Lybrand Consulting, Inc., a Consultant by Health Care Group, Inc., a Chairman by Karos Pharmaceuticals, Inc., and a Principal by Smithkline Beecham Pharmaceuticals (Canada).
He also served on the board at Aspreva Pharmaceuticals Corp., Corixa Corp., Cerexa, Inc., IlluminOss Medical, Inc., Inform Diagnostics, Inc., Kalidex Pharmaceuticals, Inc., Neuromed Pharmaceuticals Ltd., Phase Forward, Inc. and Stromedix, Inc. He received his undergraduate degree from Cornell University and an MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
RALLYBIO CORPORATION -.--% | 18/02/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Posizioni attive di Ron Hunt
| Società | Posizione | Inizio |
|---|---|---|
| RALLYBIO CORPORATION | Direttore/Membro del Consiglio | 01/03/2018 |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel treatments for psychiatric and neurodegenerative diseases | Direttore/Membro del Consiglio | - |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Direttore/Membro del Consiglio | - |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direttore/Membro del Consiglio | - |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Direttore/Membro del Consiglio | - |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Fondatore | 01/07/2005 |
Qlaris Bio, Inc.
 Qlaris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for debilitating ophthalmic diseases | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Ron Hunt
| Società | Posizione | Fine |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Presidente | 14/02/2025 |
| HARPOON THERAPEUTICS, INC. | Presidente | 26/10/2021 |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Ron Hunt
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
67
Relazioni di 1° grado
29
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 29 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Neuronetics, Inc.
 Neuronetics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes non-invasive therapies for psychiatric and neurological disorders | Health Technology |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs to treat fibrosis and fibrotic organ failure | Health Technology |
IlluminOss Medical, Inc.
 IlluminOss Medical, Inc. Medical SpecialtiesHealth Technology Designs, develops and markets orthopedic fracture repair products | Health Technology |
Kalidex Pharmaceuticals, Inc.
 Kalidex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops antibiotics for the treatment of serious infections | Health Technology |
Sprout Group
 Sprout Group Investment ManagersFinance Sprout invest in companies located in North America. The firm focuses communications, software, services & e-commerce and healthcare technology sectors. | Finance |
Phase Forward, Inc.
 Phase Forward, Inc. Packaged SoftwareTechnology Services Develops e-process software solutions for accelerating global pharmaceutical development | Technology Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neuromed Pharmaceuticals Ltd.
 Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops chronic pain drugs | Health Technology |
Inform Diagnostics, Inc.
 Inform Diagnostics, Inc. Hospital/Nursing ManagementHealth Services Provides pathology diagnostic services | Health Services |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Coopers & Lybrand Consulting, Inc.
 Coopers & Lybrand Consulting, Inc. Information Technology ServicesTechnology Services Provides computer software development services | Technology Services |
Health Care Group, Inc. | |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Smithkline Beecham Pharmaceuticals (Canada) | |
Karos Pharmaceuticals, Inc.
 Karos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
CuraSen Therapeutics, Inc.
CuraSen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel treatments for psychiatric and neurodegenerative diseases | Health Technology |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Health Technology |
Iterum Therapeutics US Holding Ltd.
Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Qlaris Bio, Inc.
Qlaris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for debilitating ophthalmic diseases | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
